Skip to content

A Volumetric Coiling in Aneurysm Registry of the Penumbra Coil 400TM System

VOLCAN: A Volumetric Coiling in Aneurysm Registry of the Penumbra Coil 400TM System

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01754051
Acronym
VOLCAN
Enrollment
100
Registered
2012-12-21
Start date
2013-01-31
Completion date
2017-10-03
Last updated
2018-05-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intracranial Aneurysms

Brief summary

This study is a prospective, multi-center registry of patients with intracranial aneurysms who are treated by the PC 400 System. Data for each patient are collected up to 12 ± 3 months post-procedure for the study.

Interventions

DEVICEPC 400 coils

Sponsors

Penumbra Inc.
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients older than 18 years * Intracranial aneurysms \>2mm, ruptured or unruptured

Exclusion criteria

* Fusiform aneurysms * Dissecting aneurysms * Aneurysms associated with brain AVMs * Multiple aneurysms * Re-treated aneurysms * Patients in whom endovascular embolization therapies other than PC 400 System are used will be excluded from this study. However, adjunctive use of balloon and stent are acceptable.

Design outcomes

Primary

MeasureTime frame
Packing density with the number of coils implantedDuring the procedure
Time of fluoroscopic exposureDuring the procedure
Procedural device-related serious adverse events at immediate post-procedureDuring the procedure
Quality of aneurysm occlusion post-operatively and at 12±3 months post-procedure based on the Raymond ScaleAt 1 year post-procedure

Secondary

MeasureTime frame
Acute occlusion of the aneurysm sac at immediate post-procedureAt immediate post-procedure
Adverse events occurring during the procedure and in the 30±7 days following the treatment.During and at 30 days post-procedure

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026